1. Home
  2. HCWB vs MIND Comparison

HCWB vs MIND Comparison

Compare HCWB & MIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCWB
  • MIND
  • Stock Information
  • Founded
  • HCWB 2018
  • MIND 1987
  • Country
  • HCWB United States
  • MIND United States
  • Employees
  • HCWB N/A
  • MIND N/A
  • Industry
  • HCWB Biotechnology: Pharmaceutical Preparations
  • MIND Industrial Machinery/Components
  • Sector
  • HCWB Health Care
  • MIND Industrials
  • Exchange
  • HCWB Nasdaq
  • MIND Nasdaq
  • Market Cap
  • HCWB 17.2M
  • MIND 74.4M
  • IPO Year
  • HCWB 2021
  • MIND 1994
  • Fundamental
  • Price
  • HCWB $0.35
  • MIND $6.60
  • Analyst Decision
  • HCWB
  • MIND
  • Analyst Count
  • HCWB 0
  • MIND 0
  • Target Price
  • HCWB N/A
  • MIND N/A
  • AVG Volume (30 Days)
  • HCWB 281.9K
  • MIND 361.6K
  • Earning Date
  • HCWB 03-31-2025
  • MIND 04-28-2025
  • Dividend Yield
  • HCWB N/A
  • MIND N/A
  • EPS Growth
  • HCWB N/A
  • MIND N/A
  • EPS
  • HCWB N/A
  • MIND 6.61
  • Revenue
  • HCWB $3,495,990.00
  • MIND $45,197,000.00
  • Revenue This Year
  • HCWB $229.19
  • MIND $22.98
  • Revenue Next Year
  • HCWB N/A
  • MIND $10.18
  • P/E Ratio
  • HCWB N/A
  • MIND $1.00
  • Revenue Growth
  • HCWB 22.27
  • MIND 41.23
  • 52 Week Low
  • HCWB $0.21
  • MIND $3.05
  • 52 Week High
  • HCWB $2.52
  • MIND $11.10
  • Technical
  • Relative Strength Index (RSI)
  • HCWB 46.07
  • MIND 30.81
  • Support Level
  • HCWB $0.33
  • MIND $6.70
  • Resistance Level
  • HCWB $0.38
  • MIND $7.89
  • Average True Range (ATR)
  • HCWB 0.03
  • MIND 0.89
  • MACD
  • HCWB -0.00
  • MIND -0.33
  • Stochastic Oscillator
  • HCWB 33.18
  • MIND 3.18

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.

About MIND MIND Technology Inc. (DE)

MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The Company operates in segments namely, Seamap Marine Products and Klein Marine Products helps manufacture and sell specialized, high-performance sonar and seismic equipment. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; Europe, Russia & CIS; Middle East & Africa; Asia-Pacific; and Canada & Latin America.

Share on Social Networks: